Evidence map›Paper›PMID 37846490›Full record

ArticleEMBO reports2023

CCR4-NOT differentially controls host versus virus poly(a)-tail length and regulates HCMV infection.

Hannah M Burgess, Rebecca Grande, Sofia Riccio, Ikshitaa Dinesh, Gerlof Sebastiaan Winkler, Daniel P Depledge, Ian Mohr

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Extended poly(A) tails are a shared feature of herpesvirus mRNAs.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Nanopore Guided Annotation of Transcriptome Architectures.bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Hannah M BurgessDepartment of Microbial Sciences, University of Surrey, Guildford, UK.ORCID 0000-0003-3577-4746
Rebecca GrandeDepartment of Microbiology, School of Medicine, New York University, New York, NY, USA.ORCID 0000-0001-6840-6718
Sofia RiccioDepartment of Microbial Sciences, University of Surrey, Guildford, UK.ORCID 0009-0005-0575-0681
Ikshitaa DineshDepartment of Microbial Sciences, University of Surrey, Guildford, UK.ORCID 0009-0008-2045-8816
Gerlof Sebastiaan WinklerSchool of Pharmacy, University of Nottingham, Nottingham, UK.ORCID 0000-0002-0476-162X
Daniel P DepledgeDepartment of Microbiology, School of Medicine, New York University, New York, NY, USA.ORCID 0000-0002-4292-0599
Ian MohrDepartment of Microbiology, School of Medicine, New York University, New York, NY, USA.
University of Surrey · GBCourant Institute of Mathematical Sciences · USMedizinische Hochschule Hannover · DENew York University · USUniversity of Nottingham · GB

Funding

INFECTIOUS DISEASES &BASIC MICROBIOLOGICAL MECHANISMST32AI007180 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEISER, JEFFREY NEAL · 1985 to 2022
$8.9M
Control of Translation in Herpesvirus Infected Cells - Resubmission - 1R01GM056927 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Ian J Mohr · 1999 to 2026
$7.6M
Virus Host Interactions that Regulate Translation in Cells Infected with HSV-1R01AI073898 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MOHR, IAN J · 2008 to 2020
$5.0M
Training Program in Immunology and Inflammation.T32AI100853 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Susan Ruth Schwab · 2012 to 2026
$4.5M
EPITRANSCRIPTOMIC REGULATION OF CYTOMEGALOVIRUS INFECTIONR01AI152543 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DEPLEDGE, DANIEL PEARCE, MOHR, IAN J · 2020 to 2025
$2.7M
Control of antiviral immunity by RNA decayR21AI126102 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MOHR, IAN J · 2016 to 2017
$466k
Cellular RNAs in anti-viral immunity to HSV1 - Resubmission - 1R21AI151436 · NIAID · UNIVERSITY OF SURREY · PI BURGESS, HANNAH MARION · 2021 to 2022
$389k
Circular RNAs in HSV1 infection and antiviral immunityR21AI166638 · NIAID · UNIVERSITY OF SURREY · PI BURGESS, HANNAH MARION · 2021 to 2022
$194k
Medical Research Council G1100205NIAID NIH HHS R01 AI073898NIAID NIH HHS R01 AI152543NIAID NIH HHS R21 AI126102NIAID NIH HHS R21 AI151436NIAID NIH HHS R21 AI166638NIAID NIH HHS T32 AI007180NIAID NIH HHS T32 AI100853NIGMS NIH HHS R01 GM056927
6 · The paper itself

Abstract

Unlike most RNA and DNA viruses that broadly stimulate mRNA decay and interfere with host gene expression, human cytomegalovirus (HCMV) extensively remodels the host translatome without producing an mRNA decay enzyme. By performing a targeted loss-of-function screen in primary human fibroblasts, we here identify the host CCR4-NOT deadenylase complex members CNOT1 and CNOT3 as unexpected pro-viral host factors that selectively regulate HCMV reproduction. We find that the scaffold subunit CNOT1 is specifically required for late viral gene expression and genome-wide host responses in CCR4-NOT-disrupted cells. By profiling poly(A)-tail lengths of individual HCMV and host mRNAs using nanopore direct RNA sequencing, we reveal poly(A)-tails of viral messages to be markedly longer than those of cellular mRNAs and significantly less sensitive to CCR4-NOT disruption. Our data establish that mRNA deadenylation by host CCR4-NOT is critical for productive HCMV replication and define a new mechanism whereby herpesvirus infection subverts cellular mRNA metabolism to remodel the gene expression landscape of the infected cell. Moreover, we expose an unanticipated host factor with potential to become a therapeutic anti-HCMV target.

Indexed as

Herpesviridae InfectionsTranscription FactorsHumansReceptors, CCR4RNA, MessengerCCR4 protein, humanCNOT1 protein, humanCNOT3 protein, humanReceptors, CCR4RNA, MessengerTranscription FactorsCCR4-NOTdeadenylationHCMVRNA decayvirus:host interaction

Identifiers

PMID37846490
PMCPMC10702830
OpenAlexW4387691694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.